ALIEN-WORLDS
28.3.2022 15:11:05 CEST | Business Wire | Press release
Minecraft , the best-selling video game in history engaging more than 170 million players, will be able to earn Trilium, the native cryptocurrency in the Alien Worlds metaverse. Alien Worlds is one of the largest play to earn (P2E) blockchain games and NFT metaverse.
Launched in 2020, Alien Worlds has grown to be the second largest blockchain platform by monthly active users. In the game, users can play with unique digital items (NFTs), stake Trilium tokens, travel on Alien Worlds Missions to other planets, vote in elections, and run for planetary council. The game’s 6 planet DAOs compete with each other for Trilium, encouraging user collaboration.
The new interoperability bridge to the world’s longest running and most popular online building platform will have resounding effects in the traditional and blockchain gaming worlds. The bridge will accelerate the onboarding of non-blockchain gamers onto the Alien Worlds metaverse, and also due to the open sourced nature of the code developed - empower other Minecraft servers to earn play-to-earn rewards. Plus, it will allow other blockchain projects to tap into Minecraft's vast user base.
Additionally, this interoperability will offer traditional gamers the opportunity to earn assets, in this case Trilium, and soon NFTs, for completing quests. Players are able to exchange their digital assets freely, enabling them to earn real world utility by getting involved in Alien Worlds’ simulated economy.
“This bridge is significant in that we are linking one of the world’s most popular decentralized games to the blockchain, and opening up a world of new possibilities for Minecraft players through our social metaverse,” says Alien Worlds co-founder Saro McKenna. “We think our combination of economics, team strategy and earning will convert Minecraft players of all ages into Web3 players.”
Additionally, earning Trilium will allow Minecraft gamers to stake the fungible token to one of the Alien Worlds Planet DAOs, which hold some of the largest treasuries in the space. Staked Trilium translates into voting power to determine control of planetary treasuries. Minecraft players will not only be able to learn about DAOs, but also to participate in the collaborative, competitive and highly strategic environment that their gamification entails.
About Alien Worlds
Alien Worlds is a breakthrough NFT Metaverse and one of the world’s most popular play-to-earn blockchain games, where users can play with unique digital assets (NFTs), stake Trilium tokens, travel on Missions to the planets, vote in elections, and run for planetary council. The game’s 6 planet DAOs compete with each other for Trilium, allowing users to collaborate, compete and strategize with one another.
With almost 7 million all-time players and more than 700,000 Monthly Active Users (number of unique wallet addresses interacting with Alien Worlds' smart contracts on a monthly basis, DappRadar ), Alien Worlds has rapidly climbed the DappRadar ranking charts and inspired individuals to scale new heights of imagination in order to create, share and thrive in the Social Metaverse.
To access and play Alien Worlds and the new Alien Worlds Missions game, visit www.alienworlds.io , play.alienworlds.io/missions and the Explorers Station .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220328005182/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom